About this resource:
Non-Systematic Review
Source: Substance Abuse and Mental Health Services Administration
Last Reviewed: September 2021
Workgroups: Substance Use Workgroup
This Substance Abuse and Mental Health Services Administration (SAMHSA) guide presents 3 evidence-based practices that engage and improve outcomes for people with concurrent substance use and concurrent substance use disorders:
- FDA-approved pharmacotherapy, together with counseling, to treat alcohol and cocaine dependence or cocaine and opioid dependence
- Contingency management, together with FDA-approved pharmacotherapy and counseling, to treat cocaine and opioid use and dependence or cocaine dependence and alcohol and opioid use
- 12-step facilitation therapy, together with FDA-approved pharmacotherapy and counseling, to treat cocaine and opioid dependence or opioid and other substance dependence
Objectives related to this resource (1)
Little or no detectable change
Suggested Citation
1.
Substance Abuse and Mental Health Services Administration. (2021). Treating Concurrent Substance Use Among Adults. Retrieved from https://www.samhsa.gov/resource/ebp/treating-concurrent-substance-use-among-adults.
